Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 58497-00-0
2. Rs-2362
3. D04s7vlm8q
4. 6alpha,9-difluoro-11beta-hydroxy-16alpha,17-[isopropylidenebis(oxy)]pregna-1,4-diene-3,20-dione 21-propionate
5. [2-[(1s,2s,4r,8s,9s,11s,12r,13s,19s)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] Propanoate
6. Procinonida
7. Procinonidum
8. 6alpha,9-difluoro-11beta-hydroxy-16alpha,17-(isopropylidenebis(oxy))pregna-1,4-diene-3,20-dione 21-propionate
9. Procinonide [usan:inn]
10. Procinonidum [inn-latin]
11. Unii-d04s7vlm8q
12. Procinonida [inn-spanish]
13. Einecs 261-289-9
14. Fluocinolone Acetonide 21-propionate
15. Procinonide [inn]
16. Procinonide (usan/inn)
17. Procinonide [usan]
18. Schembl8410
19. Procinonide [mart.]
20. Procinonide [who-dd]
21. Chembl2106554
22. Dtxsid501024163
23. Zinc4214190
24. 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-propionate
25. D05616
26. Q27275923
27. 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-propionate
28. Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.alpha)-
29. Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(1-oxopropoxy)-, (6alpha,11beta,16alpha)-
| Molecular Weight | 508.5 g/mol |
|---|---|
| Molecular Formula | C27H34F2O7 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 508.22725974 g/mol |
| Monoisotopic Mass | 508.22725974 g/mol |
| Topological Polar Surface Area | 99.1 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 1080 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Procinonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Procinonide, including repackagers and relabelers. The FDA regulates Procinonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Procinonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Procinonide supplier is an individual or a company that provides Procinonide active pharmaceutical ingredient (API) or Procinonide finished formulations upon request. The Procinonide suppliers may include Procinonide API manufacturers, exporters, distributors and traders.
click here to find a list of Procinonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Procinonide DMF (Drug Master File) is a document detailing the whole manufacturing process of Procinonide active pharmaceutical ingredient (API) in detail. Different forms of Procinonide DMFs exist exist since differing nations have different regulations, such as Procinonide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Procinonide DMF submitted to regulatory agencies in the US is known as a USDMF. Procinonide USDMF includes data on Procinonide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Procinonide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Procinonide suppliers with USDMF on PharmaCompass.
Procinonide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Procinonide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Procinonide GMP manufacturer or Procinonide GMP API supplier for your needs.
A Procinonide CoA (Certificate of Analysis) is a formal document that attests to Procinonide's compliance with Procinonide specifications and serves as a tool for batch-level quality control.
Procinonide CoA mostly includes findings from lab analyses of a specific batch. For each Procinonide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Procinonide may be tested according to a variety of international standards, such as European Pharmacopoeia (Procinonide EP), Procinonide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Procinonide USP).
LOOKING FOR A SUPPLIER?
